<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: The CHADS(2) score is used for risk stratification of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> in patients with nonvalvular <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> and high CHADS(2) scores are associated with increased risk of <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Most components of the CHADS(2) score are also risk factors for <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore, high CHADS(2) scores can be associated with concomitant cerebral <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and subsequently atherothrombotic <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The aim of this study was to determine whether there are differences in the presence and burden of concomitant cerebral <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> according to CHADS(2) scores in patients with <z:hpo ids='HP_0001297'>stroke</z:hpo> with nonvalvular <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: We included 780 consecutive patients with nonvalvular <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> who had undergone angiographic studies at index <z:hpo ids='HP_0001297'>stroke</z:hpo> between August 1994 and March 2010 in the present study </plain></SENT>
<SENT sid="5" pm="."><plain>We investigated the relationships between the CHADS(2) score and the presence, severity, and pattern of cerebral <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and <z:hpo ids='HP_0001297'>stroke</z:hpo> mechanism </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Of the 780 patients, concomitant <z:hpo ids='HP_0100545'>arterial stenosis</z:hpo> (â‰¥50%) was found in 231 patients (29.6%) </plain></SENT>
<SENT sid="7" pm="."><plain>The number of arteries with <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> increased as the CHADS(2) score increased (P&lt;0.001) as did the proportion of combined extracranial and intracranial <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> (P&lt;0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>Multivariate analyses showed that high risk based on the CHADS(2) score was an independent predictor of concomitant cerebral <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> (OR, 3.121; 95% CI, 1.770 to 5.504) and the presence of proximal stenosis at the symptomatic artery (OR, 3.043; 95% CI, 1.458 to 6.350) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: The CHADS(2) score can predict the presence of concomitant <z:hpo ids='HP_0007201'>cerebral artery atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>Increased risk of <z:hpo ids='HP_0001297'>stroke</z:hpo> in patients with high CHADS(2) scores may be partly explained by increased frequency and burden of cerebral <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
</text></document>